top of page
Achievements
사각형

Patents Overview

by Status

Total

00

Granted

00

Filed

00

by Technology

Navibody

00

rBoNT

00

Virucidal Therapeutics

00

Patent List

MVRIX is building its intellectual property portfolio as both the outcome of our three platform technologies and the engine driving our business growth.

View all

Filed

PCT

Jul 1, 2025

내비바디

P53 단백질을 암호화하는 mRNA가 탑재되어 있는 HER2 결합 지질나노입자를 함유하는 약학 조성물

Filed

PCT

Jul 1, 2025

내비바디

표적 전달능 및 안전성이 개선된 지질나노입자 약학 조성물

Filed

KR

Jun 30, 2025

내비바디

표적 전달능 및 안전성이 개선된 지질나노입자 약학 조성물

Filed

KR

Jun 25, 2025

내비바디

mRNA 지질나노입자 기반 in vivo CAR-T 기술을 이용한 자가면역치료제

Filed

KR

Jun 25, 2025

내비바디

mRNA 지질나노입자 기반 in vivo CAR-T 기술을 이용한 림프구성 혈액암 치료제

Filed

KR

May 11, 2025

내비바디

암과 수지암과 수지상세포에 항원을 동시 전달할 수 있는 지질나노입자 및 이를 함유하는 항암 조성물

Filed

KR

Mar 30, 2025

내비바디

클러스테린이 융합된 항체 및 이 항체가 자기결합하여 형성된 항체결합 지질나노입자

Filed

PCT

Mar 6, 2025

재조합 보툴리눔 독소

Method for producing botulinum toxin using soluble partner and intein

Filed

PCT

Jan 2, 2025

살바이러스

Nanodisc comprising virus receptor and fc fragment, and antiviral use thereof

Filed

KR

Oct 24, 2024

재조합 보툴리눔 독소

FGF 단백질과 BoNT 단백질이 융합된 FGF-BoNT 융합단백질 및 이를 함유하는 화장료 조성물

Filed

KR

Oct 24, 2024

살바이러스

sACE2 나노디스크를 함유하는 특발성 폐 섬유화증의 예방 또는 치료용 약학 조성물

Filed

PCT

Oct 3, 2024

살바이러스

Nanodisc using dimer bonding

Filed

PCT

Oct 3, 2024

살바이러스

Nanodisc comprising angiotensin-converting enzyme 2 and fc fragment, and use thereof

Filed

CN

Aug 29, 2024

내비바디

Antibody-binding lipid nanoparticles comprising antibodies bound to membrane scaffold proteins

Filed

IN

Aug 26, 2024

내비바디

Antibody-binding lipid nanoparticle with antibody bound to membrane scaffold protein

Filed

US

Aug 20, 2024

살바이러스

Nanodisc comprising angiotensin converting enzyme 2

Filed

EU

Aug 18, 2024

내비바디

Antibody-bound lipid nanoparticle comprising antibody bound to membrane scaffold protein

Filed

US

Jul 26, 2024

내비바디

Antibody-bound lipid nanoparticle comprising antibody bound to membrane scaffold protein

Filed

JP

Jul 25, 2024

내비바디

Antibody-binding lipid nanoparticle with antibody bound to membrane scaffold protein

Filed

KR

Jul 2, 2024

내비바디

p53 단백질을 암호화하는 mRNA가 탑재되어 있는 HER2 결합 지질나노입자를 함유하는 약학 조성물

Filed

KR

Jun 25, 2024

살바이러스

Nanodisc containing membrane scaffold protein fused with angiotensin converting enzyme 2 and and its antiviral use therof

Filed

KR

Mar 19, 2024

살바이러스

Nanodisc comprising angiotensin converting enzyme 2 fused with Fc fragment and use thereof

Filed

US

Mar 8, 2024

살바이러스

Viral receptor bound with sialic acid compounds

Filed

KR

Mar 7, 2024

재조합 보툴리눔 독소

가용화 파트너 및 인테인을 이용한 보툴리눔 독소 생산방법

Filed

PCT

Jan 29, 2024

살바이러스

Nanodiscs comprising fab fragments and fc fragments of antibody and antiviral use thereof

Filed

KR

Dec 15, 2023

살바이러스

Nanodisc containing membrane scaffold protein fused with angiotensin converting enzyme 2 and and its antiviral use therof

Filed

US

Oct 19, 2023

살바이러스

Pharmaceutical composition for preventing or treating virus infections, comprising polymer nanodiscs

Filed

CN

Oct 13, 2023

살바이러스

Pharmaceutical composition for preventing or treating viral infections comprising polymeric nanodisks

Filed

EU

Oct 9, 2023

살바이러스

Pharmaceutical composition for preventing or treating virus infections, comprising polymer nanodiscs

Filed

PCT

Jul 4, 2023

살바이러스

Nanodisc comprising membrane scaffold protein having fc region of antibody fused thereto

Filed

PCT

Feb 9, 2023

살바이러스

Nanodisc comprising angiotensin converting enzyme 2 and antiviral use thereof

Filed

PCT

Feb 9, 2023

살바이러스

Nanodisc comprising angiotensin converting enzyme 2
Abstract

Filed

PCT

Jan 26, 2023

내비바디

Antibody-bound lipid nanoparticle comprising antibody bound to membrane scaffold protein

Filed

KR

Jul 5, 2022

살바이러스

바이러스 치료제용 면역디스크

Filed

PCT

Apr 17, 2022

살바이러스

Pharmaceutical composition for preventing or treating virus infections, comprising polymer nanodiscs

Filed

PCT

Apr 17, 2022

재조합 보툴리눔 독소

Protein complex including botulinum toxin translocation domain and endolysin and antibacterial composition including same

Filed

EU

Mar 24, 2022

살바이러스

Nano-perforator having improved anti-viral activity

Filed

US

Mar 23, 2022

살바이러스

Nano-perforator having improved anti-viral activity

Filed

IN

Mar 23, 2022

살바이러스

항-바이러스 활성이 향상된 나노 천공자

Filed

CN

Mar 22, 2022

살바이러스

Nanoperforator with enhanced antiviral activity

Filed

US

Mar 18, 2022

살바이러스

Tag protein for increasing water solubility and heat stability of target protein, and fusion protein comprising same

Filed

EU

Feb 22, 2022

재조합 보툴리눔 독소

Method for safely producing botulinum neurotoxin

Filed

IN

Feb 21, 2022

재조합 보툴리눔 독소

Method for safely producing botulinum neurotoxin

Filed

KR

Jan 27, 2022

살바이러스

지질나노입자를 형성하는 항체

Filed

PCT

Dec 17, 2020

재조합 보툴리눔 독소

Method for safely producing botulinum neurotoxin

Filed

PCT

Sep 21, 2020

살바이러스

Nano-perforator having improved anti-viral activity

Filed

PCT

Sep 17, 2020

살바이러스

Tag protein for increasing water solubility and heat stability of target protein, and fusion protein comprising same

10-2817110

KR

May 30, 2025

살바이러스

Nanodisc with antibody's Fab and Fc fragment

10-2790255

KR

Mar 28, 2025

재조합 보툴리눔 독소

Recombinant botulinum toxin and pharmaceutical compositions containing the same

12,171,814

US

Dec 24, 2024

재조합 보툴리눔 독소

Protein complex including botulinum toxin translocation domain and endolysin and antibacterial composition including same

12,171,815

US

Dec 24, 2024

재조합 보툴리눔 독소

Method for safely producing botulinum neurotoxin

10-2743941

KR

Dec 12, 2024

살바이러스

Nanodisc with virus receptor and Fc fragment and antiviral uses thereof

10-2743940

KR

Dec 12, 2024

살바이러스

Nanodisc with angiotensin converting enzyme 2 and Fc fragment and uses thereof

10-2737761

KR

Nov 28, 2024

살바이러스

Nanodisc containing membrane scaffold protein fused with Fc region of antibody and viral receptor

10-2731131

KR

Nov 12, 2024

재조합 보툴리눔 독소

Method for Producing botulinum neurotoxin using soluble partner and GP41.1 intein

10-2729353

KR

Nov 7, 2024

살바이러스

Nanodisc containing membrane scaffold protein fused with Fc region of antibody

10-2702394

KR

Aug 29, 2024

살바이러스

Nanodisc using dimer binding

10-2698524

KR

Aug 20, 2024

내비바디

Antibody-binding lipid nanoparticle with antibody bound to membrane scaffold protein

10-2695049

KR

Aug 8, 2024

살바이러스

Nanodisk with large membrane scffold protein

10-2695050

KR

Aug 8, 2024

살바이러스

Dual nanodisk with multiple nanodisks combined

ZL 202080059073.1

CN

Aug 6, 2024

재조합 보툴리눔 독소

Safe preparation of botulinum neurotoxin

10-2675750

KR

Jun 12, 2024

살바이러스

Nano-perforator having enhanced antiviral activity

11,957,697

US

Apr 16, 2024

살바이러스

Viral receptor bound with sialic acid compounds

10-2613552

KR

Dec 8, 2023

살바이러스

Tag protein for increasing solubility and thermal stability of target protein and fusion protein containing the same

10-2610178

KR

Nov 30, 2023

살바이러스

Nanodisc containing membrane scaffold protein fused with angiotensin converting enzyme 2

10-2610179

KR

Nov 30, 2023

재조합 보툴리눔 독소

A method for safe production of botulinum neurotoxin

10-2597062

KR

Oct 27, 2023

재조합 보툴리눔 독소

A method for safe production of botulinum neurotoxin using 3-part fragment production

10-2556037

KR

Jul 11, 2023

살바이러스

Pharmaceutical Composition for Preventing or Treating Viral Infection Comprising Polymer Nanodiscs

10-2547393

KR

Jun 20, 2023

재조합 보툴리눔 독소

Protein Complex Comprising Botulinum Toxin Translocation Domain and Endolysin, and Anti-Bacterial Composition Comprising Thereof

10-2540330

KR

May 31, 2023

살바이러스

Nanodisc with phosphatidylethanolamine phospholipid

10-2540331

KR

May 31, 2023

살바이러스

Polymer nanodisc with angiotensin converting enzyme 2 and its antiviral usage

11,541,100

US

Jan 3, 2023

살바이러스

Pharmaceutical composition comprising nanoperforator for preventing or treating viral infectious diseases

10-2438720

KR

Aug 26, 2022

살바이러스

Nanodisc with angiotensin converting enzyme 2 and its antiviral usage

10-2438721

KR

Aug 26, 2022

살바이러스

Nanodisc with angiotensin converting enzyme 2 and its usage for disease from angiotensin converting enzyme 2 deficiency

10-2417845

KR

Jul 1, 2022

살바이러스

A viral receptor mimic compound bound with sialic acid compounds

10-2393872

KR

Apr 28, 2022

살바이러스

Antiviral peptide from M2 protein and the use thereof

10-2181991

KR

Nov 17, 2020

살바이러스

Nano-perforator and pharmaceutical composition comprising the same for preventing or treating viral infection

10-1647178

KR

Aug 3, 2016

내비바디

Stabilized Plasmid-Lipid Particles Using polyethylen glycol-lipid composed of an Enzymatically Cleavable Linker or oligo-lysines

10-1536037

KR

Jul 6, 2015

살바이러스

Antibody-drug conjugate comprising apolipoprotein

10-1455909

KR

Oct 22, 2014

살바이러스

pH-responsive high density lipoprotein-like particle conjugate

bottom of page